Advanced Search
GUO Renhong, TANG Guidi, PAN Liangxi, HUANG Xinen, FENGJifeng, ZHANG Quanan. Cl inical Observation of Docetaxel Combined with Low2dose Cisplatin for Treating Advanced Non2small Cell Lung Cancer in Elderly Patients[J]. Cancer Research on Prevention and Treatment, 2008, 35(01): 52-54. DOI: 10.3971/j.issn.1000-8578.3223
Citation: GUO Renhong, TANG Guidi, PAN Liangxi, HUANG Xinen, FENGJifeng, ZHANG Quanan. Cl inical Observation of Docetaxel Combined with Low2dose Cisplatin for Treating Advanced Non2small Cell Lung Cancer in Elderly Patients[J]. Cancer Research on Prevention and Treatment, 2008, 35(01): 52-54. DOI: 10.3971/j.issn.1000-8578.3223

Cl inical Observation of Docetaxel Combined with Low2dose Cisplatin for Treating Advanced Non2small Cell Lung Cancer in Elderly Patients

More Information
  • Received Date: January 08, 2007
  • Revised Date: March 04, 2007
  • Objective  To evaluated the efficacy and toxicity of Docetaxel combined with low2dose Cisplatin as alternative chemotherapy for elderly patient s with advanced non small cell lung cancer (NSCLC) . Methods  Thirty2one patient s were enrolled in the study. Each was t reated as following : Docetaxel 40mg/ m2 infusion once per week for two weeks ; Cisplatin 14mg/ m2 / d infusion on day1~5. Af ter 2 con2 secutive t reatment course, each for 4 weeks, evaluation of the short2term efficacy and adverse effect s was carried out . Results  The overall response rate was 32. 3 %(10/ 31) . CR0 (0 %), PR10 (32. 3 %), SD16 (51. 6 %), PD5 (16. 1 %), median OS was 10. 3 months. Hematologic toxicities, which were mild, in2 cluded grade Ⅲ~ Ⅳ neut ropenia in 29. 0 %(9/ 31) . The major non2hematologic toxicity was weakness (45. 2 %) . Conclusion  Weekly Docetaxel combined with low2dose Cisplatin as alternative chemotherapy is encouraging for elderly patient s with advanced NSCLC.
  • Related Articles

    [1]WU Yang, LI Tian, SHI Tingting, ZHU Lingling, ZHANG Yani, GUO Peipei, ZHANG Runbing, WANG Shunna, GAO Chun, YU Xiaohui, ZHANG Jiucong. Influencing Factors of Overall Survival of Elderly Patients with Hepatocellular Carcinoma and Construction of Prediction Model of Prognosis Nomogram: A Population-Based Study[J]. Cancer Research on Prevention and Treatment, 2024, 51(9): 756-763. DOI: 10.3971/j.issn.1000-8578.2024.24.0009
    [2]LIN Jinlan, GUO Tianxing, PAN Xiaojie, XU Zhenwu. Clinical Observation of Metronomic Oral Vinorelbine Monotherapy as First-line Treatment on Elderly Patients with Advanced Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2018, 45(11): 909-912. DOI: 10.3971/j.issn.1000-8578.2018.18.0841
    [3]ZHENG Jihua, ZHANG Weimin, XIE Bo, LIN Jinrong, ZHOU Juan, XU Zhiyong. Effi cacy and Prognostic Factors of Docetaxel or Pemetrexed as First-line Treatment for Elderly Patients with Advanced Lung Adenocarcinoma[J]. Cancer Research on Prevention and Treatment, 2014, 41(06): 641-644. DOI: 10.3971/j.issn.1000-8578.2014.06.029
    [4]DAI Xing, LI Xiangke, WU Haibo, WANG Nan, WANG Liuxing. Efficacy and Safety of S-1 as Monotherapy in Elderly Patients with Advanced Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2013, 40(05): 481-484. DOI: 10.3971/j.issn.1000-8578.2013.05.017
    [5]Gan Jialiang, Gao Feng, Cao Yunfei, Long Heng, Gan Yongsheng. Clinical Epidemiologic Analysis of 1 278 Cases of Elderly Patients with Colorectal Carcinoma in Guangxi Region[J]. Cancer Research on Prevention and Treatment, 2013, 40(01): 98-101. DOI: 10.3971/j.issn.1000-8578.2013.01.025
    [6]Wang Lijun, Feng Jilong. Three Dimensional-conformal Radiotherapy Combined with Low-dose Cisplatin in Treatment of Elderly Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2012, 39(01): 85-87. DOI: 10.3971/j.issn.1000-8578.2012.01.022
    [7]LIU Xiao-mei, ZHANG Yin-xu, LIU Heng, ZHU Zhi-tu, HA Min-wen. Maintenance Therapy with Gefitinib for Elderly Patients in Advanced Adenocarcinoma of Lung[J]. Cancer Research on Prevention and Treatment, 2011, 38(04): 444-446. DOI: 10.3971/j.issn.1000-8578.2011.04.021
    [8]CHEN Jun, XIONG Jian-ping, YING Xue-ming, ZHANG Ling, SUN Zhe, XIANG Xiao-jun. Clinical Observation of Paclitaxel Liposome Single-agent on First-line Treatment in Elderly Patients with Advanced Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2010, 37(12): 1423-1425. DOI: 10.3971/j.issn.1000-8578.2010.12.024
    [9]WU Qiong-ya, ZHOU Dao-an, LI Ai-wu, XU Ying, WU Hong-yu, CAI Yong, LIU Yu. Research of Radio-chemotherapy in Elderly Patients with Locally Advanced Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2008, 35(05): 352-354. DOI: 10.3971/j.issn.1000-8578.2834
    [10]LI Mei, MAO Guo-xin, QIAN Li, SHEN Fu. Combination of Navelbine and Carboplatin in the Elderly with Advanced Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2005, 32(09): 580-581. DOI: 10.3971/j.issn.1000-8578.3322

Catalog

    ZHANG Quanan

    1. On this Site
    2. On Google Scholar
    3. On PubMed
    Article views (3045) PDF downloads (984) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return